Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vinorelbine-Ifosfamide vs Gefitinib in EGFR-Negative NSCLC
NCT01749072Phase 2Unknown
- Sponsor
- Peking Union Medical College Hospital
- Start
- Dec 2012
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vinorelbine, ifosfamide in non-small cell lung cancer (NSCLC), sponsored by Peking Union Medical College Hospital. Status: unknown.
02
Drugs
vinorelbineifosfamide
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT01749072.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01749072.